Skip to main content
Clinical Trials/NCT01683799
NCT01683799
Completed
Not Applicable

Slow Wave Sleep and Inflammatory Processes in Pain

University of Rochester1 site in 1 country48 target enrollmentFebruary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis of the Knee
Sponsor
University of Rochester
Enrollment
48
Locations
1
Primary Endpoint
Change from baseline in nociception flexion reflex threshold
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose if the study is to determine whether improving sleep, especially slow wave or "deep" sleep, in older adults with osteoarthritis (OA) and insomnia reduces pain sensitivity and inflammatory responses to pain, and improves OA-related pain.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
August 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kathi Heffner

Associate Professor of Psychiatry

University of Rochester

Eligibility Criteria

Inclusion Criteria

  • 50-75 years of age (for women, post-menopausal)
  • Kellgren-Lawrence grade II radiographic evidence of OA affecting one or both knees
  • knee pain on most days for ≥ 6 months
  • self-reported disability due to knee pain for ≥ 2 of the following: walking, kneeling, ascending or descending stairs, or performing daily activities
  • willing and able to avoid all prescription and non-prescription, non-opiate pain medication for 48 hours prior to testing and all narcotic pain medication for 2 weeks prior to testing
  • meets research diagnostic criteria for sleep maintenance insomnia

Exclusion Criteria

  • health conditions with immunological components or undergoing or taking immunosuppressive therapies
  • conditions contraindicated for or potentially limiting ability to conduct NFR and/or cold pressor test (e.g. Raynaud's syndrome; seizures; prior MI; respiratory conditions; leg/hip nerve damage; BMI ≥ 32)
  • sleep disorders other than insomnia
  • dementia or cognitive impairment
  • history of schizophrenia or bipolar I disorder; current or recent history (within 3 months) of major psychiatric disorders
  • current depressive symptomatology or current suicidality
  • active substance dependence
  • untreated hypertension
  • use of antidepressants (stable use for 3 months okay), antipsychotics, mood stabilizers, sedative-hypnotics, opiate analgesics

Outcomes

Primary Outcomes

Change from baseline in nociception flexion reflex threshold

Time Frame: baseline and 10 weeks

Change from baseline in electrocutaneous pain threshold

Time Frame: baseline and 10 weeks

Change from baseline in minutes of time in slow wave sleep

Time Frame: baseline and 10 weeks

Change from baseline in relative power of delta EEG activity to index slow wave sleep activity

Time Frame: baseline and 10 weeks

Change from baseline in inflammatory cytokine responses to pain

Time Frame: baseline and 10 weeks

Change from baseline in Western Ontario and McMaster University OA Index

Time Frame: baseline and 10 weeks

Change from baseline in Knee Pain Scale score

Time Frame: baseline and 10 weeks

Study Sites (1)

Loading locations...

Similar Trials